Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REGN1500 in metabolic disorders
NCT02107872Phase 1Completed
- Sponsor
- Regeneron Pharmaceuticals
- Start
- Apr 2014
- Primary completion
- Sep 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of evinacumab in hypercholesterolemia, sponsored by Regeneron Pharmaceuticals. Started Apr 2014; status: completed.
02
Drugs
evinacumab
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT02107872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02107872.